Wealthfront Advisers LLC recently reduced its holdings in Pfizer Inc. by 6.5%, now owning 579,364 shares valued at $14.76 million. Despite this, other hedge funds have increased their stakes, and institutional investors collectively hold 68.36% of the company’s stock. Analysts have a “Hold” consensus rating for Pfizer, with a target price of $28.06, while the company maintains a dividend yield of 6.2% and reported strong Q4 earnings.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Wealthfront Advisers LLC Has $14.76 Million Holdings in Pfizer Inc. $PFE
Wealthfront Advisers LLC recently reduced its holdings in Pfizer Inc. by 6.5%, now owning 579,364 shares valued at $14.76 million. Despite this, other hedge funds have increased their stakes, and institutional investors collectively hold 68.36% of the company’s stock. Analysts have a “Hold” consensus rating for Pfizer, with a target price of $28.06, while the company maintains a dividend yield of 6.2% and reported strong Q4 earnings.